Iovance Biotherapeutics, Inc

IOVANASDAQ · Biological Products, (No Diagnostic Substances)

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

453.0M

on 2026-06-30, from 279.8M on 2024-03-31 10-Q ↗

Newest

No limit

S-3ASR of 2026-06-18. An automatic shelf: the form sets no dollar limit. None sold under it to 2026-10-05. S-3ASR ↗

4 of its filings are not read yet.

Warrants

The 10-Q filed 2026-08-06 is not read yet.

Cash

4.5 quarters

$297.7M on 2026-06-30 ÷ $66.0M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised: 5 of its filings are not read yet.